Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Dis ; 5: e1139, 2014 Mar 20.
Article in English | MEDLINE | ID: mdl-24651442

ABSTRACT

Critical functions of the immune system are maintained by the ability of myeloid progenitors to differentiate and mature into macrophages. We hypothesized that the cytoprotective gas molecule carbon monoxide (CO), generated endogenously by heme oxygenases (HO), promotes differentiation of progenitors into functional macrophages. Deletion of HO-1, specifically in the myeloid lineage (Lyz-Cre:Hmox1(flfl)), attenuated the ability of myeloid progenitors to differentiate toward macrophages and decreased the expression of macrophage markers, CD14 and macrophage colony-stimulating factor receptor (MCSFR). We showed that HO-1 and CO induced CD14 expression and efficiently increased expansion and differentiation of myeloid cells into macrophages. Further, CO sensitized myeloid cells to treatment with MCSF at low doses by increasing MCSFR expression, mediated partially through a PI3K-Akt-dependent mechanism. Exposure of mice to CO in a model of marginal bone marrow transplantation significantly improved donor myeloid cell engraftment efficiency, expansion and differentiation, which corresponded to increased serum levels of GM-CSF, IL-1α and MCP-1. Collectively, we conclude that HO-1 and CO in part are critical for myeloid cell differentiation. CO may prove to be a novel therapeutic agent to improve functional recovery of bone marrow cells in patients undergoing irradiation, chemotherapy and/or bone marrow transplantation.


Subject(s)
Carbon Monoxide/pharmacology , Cell Differentiation/drug effects , Heme Oxygenase-1/metabolism , Macrophages/drug effects , Membrane Proteins/metabolism , Myeloid Progenitor Cells/drug effects , Animals , Bone Marrow Transplantation , Carbon Monoxide/metabolism , Cell Lineage , Cell Proliferation , Chemokine CCL2/blood , Gases , Granulocyte-Macrophage Colony-Stimulating Factor/blood , Heme Oxygenase-1/genetics , Humans , Interleukin-1alpha/blood , Lipopolysaccharide Receptors/metabolism , Macrophage Colony-Stimulating Factor/pharmacology , Macrophages/enzymology , Macrophages/immunology , Macrophages/transplantation , Membrane Proteins/genetics , Mice , Mice, Knockout , Myeloid Progenitor Cells/enzymology , Myeloid Progenitor Cells/immunology , Myeloid Progenitor Cells/transplantation , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Receptor, Macrophage Colony-Stimulating Factor/metabolism , Signal Transduction , Time Factors , U937 Cells
2.
Am J Transplant ; 10(11): 2421-30, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20977633

ABSTRACT

Ischemia/reperfusion injury and delayed graft function (DGF) following organ transplantation adversely affect graft function and survival. A large animal model has not been characterized. We developed a pig kidney allograft model of DGF and evaluated the cytoprotective effects of inhaled carbon monoxide (CO). We demonstrate that donor warm ischemia time is a critical determinant of DGF as evidenced by a transient (4-6 days) increase in serum creatinine and blood urea nitrogen following transplantation before returning to baseline. CO administered to recipients intraoperatively for 1 h restored kidney function more rapidly versus air-treated controls. CO reduced acute tubular necrosis, apoptosis, tissue factor expression and P-selectin expression and enhanced proliferative repair as measured by phosphorylation of retinol binding protein and histone H3. Gene microarray analyses with confirmatory PCR of biopsy specimens showed that CO blocked proinflammatory gene expression of MCP-1 and heat shock proteins. In vitro in pig renal epithelial cells, CO blocks anoxia-reoxygenation-induced cell death while promoting proliferation. This large animal model of DGF can be utilized for testing therapeutic strategies to reduce or prevent DGF in humans. The efficacy of CO on improving graft function posttransplant validates the model and offers a potentially important therapeutic strategy to improve transplant outcomes.


Subject(s)
Carbon Monoxide/therapeutic use , Delayed Graft Function/drug therapy , Kidney Transplantation/physiology , Animals , Carbon Monoxide/pharmacokinetics , Cell Death/drug effects , Cell Proliferation/drug effects , Female , Gene Expression Profiling , Graft Rejection/prevention & control , Kidney/metabolism , Kidney Tubular Necrosis, Acute/etiology , Kidney Tubular Necrosis, Acute/immunology , Reperfusion Injury/prevention & control , Swine , Tacrolimus/pharmacokinetics
3.
Curr Cancer Drug Targets ; 10(4): 392-401, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20384583

ABSTRACT

Once prostate cancer becomes castration resistant, cancer cells may rapidly gain the ability to invade and to metastasize to lymph nodes and distant organs. The progression through hormone-dependent to hormone-independent/castration-resistant and metastatic PCa is poorly understood. In this review paper, we provide an overview on the cellular and molecular mechanisms underlying the process of tumor cell invasion and metastasis in prostate cancer. We specifically present the most recent findings on the role of multiple cellular signaling pathways including androgen receptor (AR), mitogen-activated protein kinases (MAPK), Akt, transforming growth factor b (TGFb interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in the development of hormone-independent/castration-resistant prostate cancer. In addition, we also discuss the recent findings on signatures of gene expression during prostate cancer progression. Our overviews on the novel findings will help to gain better understanding of the complexity of molecular mechanisms that may play an essential role in the development of castration-resistant and metastatic prostate cancer. It will also shed light on the identification of specific targets and the design of effective therapeutic drug candidates.


Subject(s)
Androgens/physiology , Neoplasm Metastasis , Prostatic Neoplasms/genetics , Disease Progression , Humans , Male , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Signal Transduction
4.
Leukemia ; 23(2): 251-61, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18987662

ABSTRACT

Alterations in the expression and signalling pathways of vascular endothelial growth factor (VEGF) have been linked to the clinical features and pathogenesis of hematologic malignancies. In this study, we showed that VEGF protein expression was statistically significantly higher in the leukemic blasts than in the normal hematopoietic counterparts. A statistically significant correlation between expression of VEGF and p27(Kip1) was observed in bone marrows from 42 patients with acute myeloid leukemia (P<0.001). We further demonstrated that forced VEGF overexpression or autocrine VEGF stimulation of VEGFR-2 triggers proliferation and migration/invasion of U-937 leukemic cells, thereby inducing a more invasive tumor phenotype. U-937 cells overexpressing VEGF were resistant to all-trans-retinoic acid-(ATRA) or camptothecin-induced apoptosis. Finally, we showed that increased p27(Kip1) expression enhanced the ability of VEGF and VEGFR-2 to promote the migration of U-937 cells. Taken together, our results suggest that elevated level of VEGF may contribute to the adverse patient outcome by promoting cell growth, survival and migration of leukemic cells and by reducing the sensitivity of leukemic cells to therapeutic agents-induced apoptosis.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p27/physiology , Leukemia, Myeloid, Acute/pathology , Vascular Endothelial Growth Factor A/physiology , Vascular Endothelial Growth Factor Receptor-2/physiology , Bone Marrow/pathology , Cell Line, Tumor , Cell Movement , Cell Proliferation , Drug Resistance, Neoplasm , Humans , Up-Regulation , Vascular Endothelial Growth Factor A/genetics
5.
Cell Mol Biol (Noisy-le-grand) ; 51(4): 347-55, 2005 Sep 30.
Article in English | MEDLINE | ID: mdl-16309584

ABSTRACT

Induction of heme oxygenase-1 (HO-1) expression can be achieved by stimulation with cobalt protoporphyrin (CoPPIX) or cobalt chloride (CoCl2). HO-1 has been recently implicated in regulation of angiogenesis and CoCl2 is known to potently activate hypoxia inducible factor-1 (HIF-1) transcription factor, a key regulator of angiogenic response in hypoxia. Here we determined the effect of CoPPIX and CoCl2 on the expression of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), the two major angiogenic mediators, in human microvascular endothelial cells (HMEC-1). CoPPIX induced HO-1 expression and strongly enhanced VEGF and IL-8 synthesis, through the activation of VEGF and IL-8 promoters. Inhibition of HO activity by SnPPIX decreased VEGF production, while, interestingly, it did not affect IL-8. CoCl2 activated hypoxia-responsive element (HRE) and consequently VEGF generation via the enhancement of production of reactive oxygen species (ROS). On the other hand, CoCl2 did not influence IL-8 expression, while CoPPIX did not induce ROS elevation neither it affected HRE activity in VEGF promoter. Our data show that although both CoCl2 and CoPPIX induce HO-1, the influence of CoCl2 on VEGF does not involve HO-1 and is HIF-1-dependent, while the effect of CoPPIX does not involve HIF-1 but relies on HO-1.


Subject(s)
Cobalt/pharmacology , Endothelial Cells/drug effects , Gene Expression Regulation/drug effects , Heme Oxygenase-1/metabolism , Interleukin-8/biosynthesis , Neovascularization, Physiologic/genetics , Protoporphyrins/pharmacology , Vascular Endothelial Growth Factor A/biosynthesis , Cells, Cultured , Endothelial Cells/metabolism , Heme Oxygenase-1/genetics , Humans , Neovascularization, Physiologic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...